DXB 2.44% 40.0¢ dimerix limited

Ann: REMAP-CAP COVID-19 Study Analysis Update, page-6

  1. 12,126 Posts.
    lightbulb Created with Sketch. 6187
    Additional Data is always valuable , Demonstrating "Anti-Viral Benefits" with your treatment has Value , Covid is one of 300 variants of the SARs Family, Covid 19,,20 ....Omicron wont be the last Malzo .

    https://hotcopper.com.au/data/attachments/4460/4460876-48b463c0687be8503832e030037eb476.jpg
    Plus the next wave is far more virulent
    https://hotcopper.com.au/data/attachments/4460/4460887-3b0fff87fc888886f853011aa57b795c.jpg
    Covid wont be the last Pandemic and Viruses are mutating everyday.... Might not be the Panacea or Silver Bullet of Today but certainly being prepared for the next outbreak would be beneficial $$$$$

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.010(2.44%)
Mkt cap ! $220.2M
Open High Low Value Volume
41.5¢ 42.0¢ 39.5¢ $839.4K 2.070M

Buyers (Bids)

No. Vol. Price($)
2 35000 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 83901 4
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.